Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuri Pekarsky

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Advances in Biological Regulation|June 7, 2026
Avoidance of immune mediated tumor rejection by cancer cellsYuri Pekarsky, Carlo M Croce
Oncotarget|October 12, 2010
Is miR-29 an oncogene or tumor suppressor in CLL?Yuri Pekarsky, Carlo M Croce
Advances in Biological Regulation|January 7, 2019
Noncoding RNA genes in cancer pathogenesisYuri Pekarsky, Carlo M Croce
Mutation Research|August 9, 2005
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer preventionNicola Zanesi, Yuri Pekarsky, Carlo M Croce
Cell Death and Differentiation|October 7, 2017
BCL2 and miR-15/16: from gene discovery to treatmentYuri Pekarsky, Veronica Balatti, Carlo M Croce
Seminars in Cancer Biology|September 25, 2010
Molecular basis of CLLYuri Pekarsky, Nicola Zanesi, Carlo M Croce
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|February 4, 2003
Targeting mature T cell leukemia: new understanding of molecular pathwaysYuri Pekarsky, Cora Hallas, Carlo M Croce
Advances in Cancer Research|September 9, 2017
Role of the tRNA-Derived Small RNAs in Cancer: New Potential Biomarkers and Target for TherapyVeronica Balatti, Yuri Pekarsky, Carlo M Croce
Journal of Cell Communication and Signaling|August 29, 2022
tRNA-derived fragments (tRFs) in cancerYuri Pekarsky, Veronica Balatti, Carlo M Croce
Best Practice & Research. Clinical Haematology|August 21, 2007
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemiaGeorge A Calin, Yuri Pekarsky, Carlo M Croce
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Advances in Biological Regulation|June 7, 2026
Avoidance of immune mediated tumor rejection by cancer cellsYuri Pekarsky, Carlo M Croce
Oncotarget|October 12, 2010
Is miR-29 an oncogene or tumor suppressor in CLL?Yuri Pekarsky, Carlo M Croce
Advances in Biological Regulation|January 7, 2019
Noncoding RNA genes in cancer pathogenesisYuri Pekarsky, Carlo M Croce
Mutation Research|August 9, 2005
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer preventionNicola Zanesi, Yuri Pekarsky, Carlo M Croce
Cell Death and Differentiation|October 7, 2017
BCL2 and miR-15/16: from gene discovery to treatmentYuri Pekarsky, Veronica Balatti, Carlo M Croce
Seminars in Cancer Biology|September 25, 2010
Molecular basis of CLLYuri Pekarsky, Nicola Zanesi, Carlo M Croce
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|February 4, 2003
Targeting mature T cell leukemia: new understanding of molecular pathwaysYuri Pekarsky, Cora Hallas, Carlo M Croce
Advances in Cancer Research|September 9, 2017
Role of the tRNA-Derived Small RNAs in Cancer: New Potential Biomarkers and Target for TherapyVeronica Balatti, Yuri Pekarsky, Carlo M Croce
Journal of Cell Communication and Signaling|August 29, 2022
tRNA-derived fragments (tRFs) in cancerYuri Pekarsky, Veronica Balatti, Carlo M Croce
Best Practice & Research. Clinical Haematology|August 21, 2007
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemiaGeorge A Calin, Yuri Pekarsky, Carlo M Croce
Pageof 6